Q2 2025 Health Catalyst Inc Earnings Call Transcript
Key Points
- Health Catalyst Inc (HCAT) reported Q2 2025 revenue of $80.7 million and adjusted EBITDA of $9.3 million, both exceeding guidance.
- The Technology segment saw an 11% year-over-year revenue growth, driven by recurring revenue from new and acquired clients.
- The company maintained robust relationships with 98 out of its 100 largest platform clients by technology revenue.
- Health Catalyst Inc (HCAT) is focused on profitability improvement, with a restructuring plan expected to enhance profitability by over $40 million annually.
- The applications revenue, which has a high gross margin of over 80%, grew more than 20% year-over-year, indicating strong cross-sell momentum.
- The company revised its full-year 2025 revenue guidance down to $310 million due to significant Medicaid and research funding cuts.
- There is a reduction in expected dollar-based retention for 2025 to the low 90s, influenced by clients pocketing savings from Ignite migrations.
- Professional Services revenue declined by 1% compared to Q2 2024, and the segment is expected to be slightly down in revenue for 2025 and 2026.
- The average booking size for new platform clients is expected to be at the lower end of the $300,000 to $700,000 range due to funding cuts.
- The company announced a workforce reduction impacting approximately 9% of its total workforce as part of its restructuring efforts.
Welcome to the Health Catalyst second quarter 2025 earnings conference call. (Operator Instructions) I would now like to turn the call over to Jack Knight, Vice President of Investor Relations.
Good afternoon, and welcome to Health Catalyst's earnings conference call for the second quarter of 2025, which ended on June 30, 2025. My name is Jack Knight. I'm the Vice President of Investor Relations for Health Catalyst. And with me on the call is Dan Burton, our Chief Executive Officer; Jason Alger, our Chief Financial Officer; and Dan LeSueur, our Chief Operating Officer. A complete disclosure of our results can be found in our press release issued today as well as in our related Form 8-K furnished to the SEC, both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com.
As a reminder, today's call is being recorded, and a replay will be available following the conclusion of the call. During today's call, we will make forward-looking statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
